Drug Trial Radar · NCT00000525
Diuretics, Hypertension, and Arrhythmias Clinical Trial
Last checked: Nov 19, 2026Latest source record: Sep 19, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
233
Actual
Start
Jul 1986
Primary completion
Sep 1989
Sponsor
- Lead sponsor
- University of California, San FranciscoAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Heart, Lung, and Blood Institute (NHLBI)
- First posted
- Oct 28, 1999
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Masking
- Double
- Who can join
- Male only, from 35 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To determine whether hypertensive patients with ECG abnormalities and receiving hydrochlorothiazide diuretics were at increased risk of sudden death.
Conditions
- Cardiovascular Diseases
- Death, Sudden, Cardiac
- Heart Arrest
- Heart Diseases
- Hypertension
Interventions
hydrochlorothiazideDrug
diet, potassium supplementationBehavioral
diet, magnesium supplementationBehavioral
triamtereneDrug
chlorthalidoneDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.